Zimmer Biomet Holdings Management
Management criteria checks 3/4
Zimmer Biomet Holdings' CEO is Ivan Tornos, appointed in Mar 2021, has a tenure of 3.17 years. total yearly compensation is $10.19M, comprised of 9.5% salary and 90.5% bonuses, including company stock and options. directly owns 0.013% of the company’s shares, worth $3.24M. The average tenure of the management team and the board of directors is 4.3 years and 9.3 years respectively.
Key information
Ivan Tornos
Chief executive officer
US$10.2m
Total compensation
| CEO salary percentage | 9.5% |
| CEO tenure | 3.2yrs |
| CEO ownership | 0.01% |
| Management average tenure | 4.3yrs |
| Board average tenure | 9.3yrs |
Recent management updates
Recent updates
The Return Trends At Zimmer Biomet Holdings (NYSE:ZBH) Look Promising
May 02
Is Zimmer Biomet Holdings (NYSE:ZBH) Using Too Much Debt?
Mar 20Zimmer Biomet Holdings (NYSE:ZBH) Will Pay A Dividend Of $0.24
Mar 02Zimmer Biomet Holdings' (NYSE:ZBH) Strong Earnings Are Of Good Quality
Feb 15What Does Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Share Price Indicate?
Feb 11Zimmer Biomet: Weight Loss Drug Concerns Are Overblown
Feb 05A Look At The Fair Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
Jan 29Zimmer Biomet: Growth Acceleration Is Likely Driven By ROSA; Initiate With 'Buy'
Jan 20Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Not Flying Under The Radar
Jan 15The Returns At Zimmer Biomet Holdings (NYSE:ZBH) Aren't Growing
Dec 31Zimmer Biomet Holdings: Visible Growth Drivers And Strong Execution
Dec 18Here's Why Zimmer Biomet Holdings (NYSE:ZBH) Can Manage Its Debt Responsibly
Dec 17Zimmer Biomet: Still Many Questions After A Solid Year So Far
Nov 26When Should You Buy Zimmer Biomet Holdings, Inc. (NYSE:ZBH)?
Nov 06Here's Why We Think Zimmer Biomet Holdings (NYSE:ZBH) Is Well Worth Watching
Oct 07Returns On Capital At Zimmer Biomet Holdings (NYSE:ZBH) Have Hit The Brakes
Sep 21Zimmer Biomet Holdings: Growth Strategies For 2023 Instill Confidence
Sep 14Calculating The Intrinsic Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
Sep 06Zimmer Biomet: Guidance Raise, Better Margins In 2024 Make It A Buy
Aug 11Is Zimmer Biomet Holdings (NYSE:ZBH) A Risky Investment?
Aug 08Should You Think About Buying Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Now?
Jul 10We Ran A Stock Scan For Earnings Growth And Zimmer Biomet Holdings (NYSE:ZBH) Passed With Ease
Jun 27Slowing Rates Of Return At Zimmer Biomet Holdings (NYSE:ZBH) Leave Little Room For Excitement
Jun 13A Look At The Fair Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
May 30Zimmer Biomet: Expect Growth Momentum To Continue
May 26Is Zimmer Biomet Holdings (NYSE:ZBH) Using Too Much Debt?
May 04At US$129, Is It Time To Put Zimmer Biomet Holdings, Inc. (NYSE:ZBH) On Your Watch List?
Apr 02Return Trends At Zimmer Biomet Holdings (NYSE:ZBH) Aren't Appealing
Mar 13A Look At The Intrinsic Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
Feb 21Improving Ortho Performance At Zimmer Biomet Is Encouraging
Feb 09Zimmer Biomet Q4 2022 Earnings Preview
Feb 02We Think Zimmer Biomet Holdings (NYSE:ZBH) Can Stay On Top Of Its Debt
Jan 19Zimmer Biomet to acquire soft tissue healing company Embody
Jan 05Zimmer Biomet declares $0.24 dividend
Dec 15Should You Think About Buying Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Now?
Dec 03Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Could Be 26% Below Their Intrinsic Value Estimate
Nov 17Zimmer Biomet reports Q3 earnings beat; raises FY22 guidance range
Nov 02Slowing Rates Of Return At Zimmer Biomet Holdings (NYSE:ZBH) Leave Little Room For Excitement
Oct 24Is Zimmer Biomet Holdings (NYSE:ZBH) A Risky Investment?
Oct 10Zimmer's shoulder replacement system Identity gets FDA clearance
Sep 20Zimmer Biomet Is Likely Set For Even More Weakness (Technical Analysis)
Sep 14Zimmer Biomet Holdings (NYSE:ZBH) Is Due To Pay A Dividend Of $0.24
Sep 12Zimmer, Surgical Planning team up to sell mixed reality navigation system HipInsight
Sep 01Zimmer Biomet Holdings (NYSE:ZBH) Will Pay A Dividend Of $0.24
Aug 29Zimmer Biomet declares $0.24 dividend
Aug 26Zimmer Biomet: Slow Growing Market Leader
Aug 20CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | US$964m |
| Dec 31 2023 | US$10m | US$969k | US$1b |
| Sep 30 2023 | n/a | n/a | US$474m |
| Jun 30 2023 | n/a | n/a | US$506m |
| Mar 31 2023 | n/a | n/a | US$450m |
| Dec 31 2022 | US$6m | US$823k | US$290m |
| Sep 30 2022 | n/a | n/a | US$366m |
| Jun 30 2022 | n/a | n/a | US$334m |
| Mar 31 2022 | n/a | n/a | US$325m |
| Dec 31 2021 | US$5m | US$731k | US$445m |
| Sep 30 2021 | n/a | n/a | US$834m |
| Jun 30 2021 | n/a | n/a | US$914m |
| Mar 31 2021 | n/a | n/a | US$563m |
| Dec 31 2020 | US$4m | US$730k | -US$11m |
| Sep 30 2020 | n/a | n/a | -US$152m |
| Jun 30 2020 | n/a | n/a | US$37m |
| Mar 31 2020 | n/a | n/a | US$377m |
| Dec 31 2019 | US$4m | US$700k | US$1b |
| Sep 30 2019 | n/a | n/a | -US$90m |
| Jun 30 2019 | n/a | n/a | -US$359m |
| Mar 31 2019 | n/a | n/a | -US$308m |
| Dec 31 2018 | US$4m | US$113k | -US$379m |
Compensation vs Market: Ivan's total compensation ($USD10.19M) is about average for companies of similar size in the US market ($USD13.62M).
Compensation vs Earnings: Ivan's compensation has increased by more than 20% in the past year.
CEO
Ivan Tornos (48 yo)
3.2yrs
Tenure
US$10,191,476
Compensation
Mr. Ivan Tornos serves as Independent External Director at PHC Holdings Corporation since September 03, 2021. He joined PHC Holdings Corporation on September 03, 2021. Mr. Tornos serves as Chief Operating...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| COO, President | 3.2yrs | US$10.19m | 0.013% $ 3.2m | |
| CFO and Executive VP of Finance | 4.8yrs | US$10.38m | 0.010% $ 2.5m | |
| Senior VP | 17yrs | US$2.87m | 0.024% $ 6.0m | |
| President of Asia Pacific | 8.9yrs | US$3.38m | 0.0088% $ 2.2m | |
| Group President of Europe | 2.9yrs | US$3.42m | 0.0035% $ 868.5k | |
| VP, Controller & Chief Accounting Officer | 2yrs | no data | 0.00046% $ 114.8k | |
| Chief Science | 2.9yrs | no data | no data | |
| Senior VP & Chief Information Officer | 7.8yrs | no data | no data | |
| SVP and Chief Communications & Administration Officer | 4.3yrs | no data | no data | |
| Director of Investor Relations | no data | no data | no data | |
| Senior VP | 8.9yrs | no data | no data | |
| Senior VP & Chief Human Resources Officer | 3.3yrs | no data | 0.0016% $ 404.3k |
4.3yrs
Average Tenure
53yo
Average Age
Experienced Management: ZBH's management team is considered experienced (4.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| COO, President | less than a year | US$10.19m | 0.013% $ 3.2m | |
| Independent Chairman of the Board | 11.8yrs | US$409.38k | 0.0017% $ 429.3k | |
| Independent Director | 15.3yrs | US$340.26k | 0.0026% $ 638.9k | |
| Independent Director | 16.2yrs | US$358.20k | 0.0019% $ 484.2k | |
| Independent Director | 9.3yrs | US$318.84k | 0.0016% $ 411.8k | |
| Independent Director | 17.3yrs | US$347.75k | 0.0016% $ 411.8k | |
| Director | less than a year | no data | no data | |
| Independent Director | 5.8yrs | US$314.44k | 0.00080% $ 199.7k | |
| Independent Director | 9.4yrs | US$342.52k | 0.00097% $ 242.1k | |
| Independent Director | 3.3yrs | US$382.35k | 0.00049% $ 122.3k | |
| Independent Director | 5.8yrs | US$367.52k | 0.0020% $ 491.7k |
9.3yrs
Average Tenure
63yo
Average Age
Experienced Board: ZBH's board of directors are considered experienced (9.3 years average tenure).